Cargando…

SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance

The cause of death among the majority of epithelial ovarian cancer (EOC) patients involves passive dissemination of cancer cells within the peritoneal cavity and subsequent implantation of cancer spheroids into adjacent organs. Thus, it is important to identify the factors that mediate EOC metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheets, J N, Iwanicki, M, Liu, J F, Howitt, B E, Hirsch, M S, Gubbels, J A A, Drapkin, R, Egland, K A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117850/ https://www.ncbi.nlm.nih.gov/pubmed/27775699 http://dx.doi.org/10.1038/oncsis.2016.64

Ejemplares similares

SUSD2 expression correlates with decreased metastasis and increased survival in a high-grade serous ovarian cancer xenograft murine model
por: Sheets, Jordan N., et al.
Publicado: (2020)

SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer
por: Hultgren, Elizabeth M., et al.
Publicado: (2017)

SUSD2 Proteolytic Cleavage Requires the GDPH Sequence and Inter-Fragment Disulfide Bonds for Surface Presentation of Galectin-1 on Breast Cancer Cells
por: Patrick, Mitch E., et al.
Publicado: (2019)

ADH1B promotes mesothelial clearance and ovarian cancer infiltration
por: Gharpure, Kshipra M., et al.
Publicado: (2018)

A Unique Pattern of Mesothelial-Mesenchymal Transition Induced in the Normal Peritoneal Mesothelium by High-Grade Serous Ovarian Cancer
por: Pakuła, Martyna, et al.
Publicado: (2019)

Clinical Relevance of Increased Endothelial and Mesothelial Expression of Proangiogenic Proteases and VEGFA in the Omentum of Patients with Metastatic Ovarian High-Grade Serous Carcinoma()()
por: Winiarski, Boleslaw K., et al.
Publicado: (2014)

High grade serous ovarian carcinomas originate in the fallopian tube
por: Labidi-Galy, S. Intidhar, et al.
Publicado: (2017)

LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
por: Sato, Sho, et al.
Publicado: (2023)

In Vitro Implantation Model Using Human Endometrial SUSD2(+)
por: Rahimipour, Marzieh, et al.
Publicado: (2021)

High Throughput Interrogation of Somatic Mutations in High Grade Serous Cancer of the Ovary
por: Matulonis, Ursula A., et al.
Publicado: (2011)

Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas
por: Milanesio, Michela Camilla, et al.
Publicado: (2020)

Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer development
por: Nameki, Robbin A., et al.
Publicado: (2023)

Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
por: Launonen, I.-M., et al.
Publicado: (2022)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
por: Gonzalez, Veronica D., et al.
Publicado: (2021)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

CCNE1 Amplification and Centrosome Number Abnormality in Serous Tubal Intraepithelial Carcinoma- Further Evidence Supporting its Role as a Precursor of Ovarian High-Grade Serous Carcinoma
por: Kuhn, Elisabetta, et al.
Publicado: (2016)

The Complement Regulator Susd4 Influences Nervous-System Function and Neuronal Morphology in Mice
por: Zhu, Hongling, et al.
Publicado: (2020)

In vivo modeling of metastatic human high-grade serous ovarian cancer in mice
por: Kim, Olga, et al.
Publicado: (2020)

Elafin drives poor outcome in high grade serous ovarian cancers and basal-like breast tumors
por: Labidi-Galy, S. Intidhar, et al.
Publicado: (2014)

Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells
por: Bilandzic, Maree, et al.
Publicado: (2019)

Intra-Tumoral Nerve-Tracing in a Novel Syngeneic Model of High-Grade Serous Ovarian Carcinoma
por: Barr, Jeffrey L., et al.
Publicado: (2021)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer
por: Chien, Jeremy, et al.
Publicado: (2015)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms
por: Jones, Paul Michael, et al.
Publicado: (2013)

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
por: Ducie, Jennifer, et al.
Publicado: (2017)

Principles of dormancy evident in high-grade serous ovarian cancer
por: Shepherd, Trevor G., et al.
Publicado: (2022)

Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma
por: Norris, Eric J, et al.
Publicado: (2019)

Structure of BT_3984, a member of the SusD/RagB family of nutrient-binding molecules
por: Bakolitsa, Constantina, et al.
Publicado: (2010)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
por: Ribeiro e Ribeiro, Renan, et al.
Publicado: (2021)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer
por: Newtson, Andreea, et al.
Publicado: (2021)

RON, ROR1 and SUSD2 expression in tissues of endometrial carcinoma patients. Clinicopathological and prognostic implications
por: Abdelbary, Abeer M., et al.
Publicado: (2022)

Trends of low-grade serous ovarian carcinoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i44jpb2fal14rflifsdmevusef